Clinical trial of thalidomide combined with radiotherapy in patients with esophageal cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 17

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

361

WORD

220

HTML

2950

Tables (1-4)

169

Sum=3700

Publishing Process of This Article

Item

Count

Browse

801

Download

812

Sum=1613

May 7, 2014 (publication date) through Aug 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastroenterol. May 7, 2014; 20(17): 5098-5103
Published online May 7, 2014. doi: 10.3748/wjg.v20.i17.5098

Table 4 Side effects in 83 evaluable esophageal cancer cases

Side effects	Group		χ²	P value
Side effects	Drug group	Non-drug group		P value
Dizziness or burnout	20	8	χ²	19.28	0.000
Somnolence	4	0	-	0.019
Grade III-IV esophagitis	4	6	0.06	0.812
Grade III-IV leukocyte decrease	2	5	0.03	0.864
Grade III-IV platelet decrease	1	3	0.02	0.961
Grade III-IV nausea and vomiting	3	14	2.913	0.089
Anaphylaxis	0	0	-	1.000

Citation: Yu JP, Sun SP, Sun ZQ, Ni XC, Wang J, Li Y, Hu LJ, Li DQ. Clinical trial of thalidomide combined with radiotherapy in patients with esophageal cancer. World J Gastroenterol 2014; 20(17): 5098-5103
URL: https://www.wjgnet.com/1007-9327/full/v20/i17/5098.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i17.5098